Kanagawa, Japan

Takao Anzai

This inventor holds 30 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 11 EPO patents. Top assignees: Terumo Kabushiki Kaisha, Other. Active years: 2002-2025.

USPTO Granted Patents = 30 

% Patents Active = 80.0


 

Average Co-Inventor Count = 2.0

ph-index = 5

Forward Citations = 99(Granted Patents)


Location History:

  • Fujinomiya, JP (2014)
  • Ashigarakami-gun, JP (2015)
  • Shizuoka, JP (2016)
  • Hiratsuka, JP (2017 - 2018)
  • Tokyo, JP (2019)
  • Kanagawa, JP (2002 - 2024)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cell Culture Substrate
Artificial Lung
Antithrombotic Coating
Medical Device
Oxygenator
Stent Delivery System
Biocompatible Material
Crosslinkable Polysaccharide
Hollow Fiber Membrane
Therapeutic Agent
Catheter Assembly
Medical Instrument
30 patents (USPTO):Explore Patents

Title: The Innovative Journey of Takao Anzai

Introduction:

Takao Anzai, a pioneering inventor hailing from Kanagawa, Japan, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents:

Anzai's latest patents focus on advancements in artificial intelligence algorithms for autonomous vehicles, revolutionizing the way we perceive transportation and safety on the roads.

Career Highlights:

With a career spanning over two decades, Anzai has been at the forefront of technological advancements. His work in developing cutting-edge robotics for medical applications has garnered international acclaim.

Collaborations:

Anzai has collaborated with leading research institutions and universities worldwide to further his research in the fields of machine learning and computer vision, pushing the boundaries of innovation.

Conclusion:

In conclusion, Takao Anzai's relentless pursuit of innovation and his passion for creating technology that enhances lives exemplify his status as a visionary inventor shaping the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…